Thompson G K, Chen K W, Yamamoto T. "Method for the Synthesis of Dasatinib Impurity 73" [P]. US Patent, US 11006559 B2, 2020-06-26.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of 达沙替尼杂质73 in Pharmaceutical Formulations". J. Nat. Prod., 2022, 945, (12), 6866-6890.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 达沙替尼杂质73 as an Impurity". J. Agric. Food Chem., 2020, 1867, 3923-3939.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of Dasatinib Impurity 73 Using HRMS and NMR". Chemosphere, 2022, 1118, (10), 4698-4726.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate 达沙替尼杂质73 Profile in Drug Substances According to ICH Guidelines". Molecules, 2025, 107, 738-755.